Contineum Therapeutics CTNM
NASDAQ CTNM
$8.45 -0.01 (-0.12%)
As of: Oct 21, 2026 · 12:56 PM EDT

Contineum Therapeutics (CTNM) Net Margin (2023)

Updated

Contineum Therapeutics (CTNM) reported Net Margin of 45.44% for FY2023.

Analysis

Contineum Therapeutics (CTNM) Net Margin (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,133.15 Bn 1,101.73 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 616.41 Bn 534.94 Bn 17.26 Bn 21.86%
3 AbbVie 501.01 Bn 474.12 Bn 12.70 Bn 21.27%
4 Merck 367.15 Bn 321.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.00 Bn 261.99 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn 16.30%
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn 23.62%
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn -134.51%
9 Pfizer 169.76 Bn 116.40 Bn 10.94 Bn -1.65%
10 Contineum Therapeutics 316.23 Mn -611.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 83.13%
API Access

Contineum Therapeutics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=CTNM&period=max&api_key=YOUR_API_KEY